News and reflections from the world of AI

    February 24, 2022

    Christina Caira reflects on use of AI in Parkinson’s disease research

    Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by the degeneration of dopamine releasing regions in the brain. The loss of dopamine leads to a chronic and progressive decrease in movement, coordination, and cognition. While there is no cure, an early diagnosis promotes treatment efficacy and prolongs a higher quality of life
    Written by Aiforia
    February 15, 2022

    Aiforia signs agreement with South Korean biotech company to augment its novel drug discovery platform with AI

    The two companies announced an agreement to add Aiforia’s artificial intelligence technology to Genuv’s ATRIVIEW® proprietary drug discovery platform, used to screen both existing drugs and new substances for neuroprotective and neuroregenerative effects. ATRIVIEW® was used to discover Genuv’s leading drug candidate, SNR1611, which has shown the ability to restore CNS function in preclinical ...
    Written by Aiforia
    January 24, 2022

    Customer case studies collection: Aiforia Education

    Professor of Veterinary Pathology at Norwegian University of Life Sciences (NMBU) Medical schools typically teach histology in the first years but competing pressures on curricula subjects have forced many educators to reduce the amount of time dedicated to normal histology. Additionally, the maintenance of numerous microscopes and slides for teaching purposes is expensive. Using fewer ...
    Written by Aiforia
    January 19, 2022

    Use of AI for identification and research of orthohantavirus infections

    Introduction Orthohantaviruses are globally spread zoonotic pathogens typically causing chronic asymptomatic infection in rodents. However, humans can be infected through contact with rodent urine, saliva, or feces, causing severe health consequences, such as hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). The mechanisms of the virus, though, are unclear.
    Written by Aiforia
    January 17, 2022

    Aiforia appoints VP of Sales, Americas

    Aiforia, a software company providing pathologists with AI-based solutions for clinical diagnostics and preclinical analysis, today announced that Marco Comianos has joined the company as VP of Sales, Americas. Comianos will oversee sales efforts, as well as driving new business, revenue growth, and more partnerships with top hospitals and pharma companies across the region.
    Written by Aiforia
    January 12, 2022

    Aiforia launches a collaboration with Mayo Clinic to transform pathology practice with AI-powered solutions

    Aiforia, a technology company providing deep learning AI software for image analysis in pathology, and Mayo Clinic announced today that they are collaborating to establish an AI-powered pathology research support architecture at the Mayo Clinic. Leveraging each other’s expertise in digital pathology and deep learning, the two aim to enable faster results and scalable studies in translational ...
    Written by Aiforia
    3 4 5 6 7